Obstructive sleep apnea, the NLRP3 inflammasome and the potential effects of incretin therapies
Obstructive sleep apnea (OSA) is a common sleep disorder associated with serious neurological and cardiovascular complications. Intermittent hypoxia and reoxygenation, a key feature of OSA, produces molecular signals that activate various inflammatory pathways, notably the inflammasome—a multiprotei...
Saved in:
Main Authors: | Michelle Wei, Jennifer A. Teske, Saif Mashaqi, Daniel Combs |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Sleep |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/frsle.2024.1524593/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Incretin hormone agonists as promising antiobesity drugs - review of literature
by: Aleksandra Grzegorczyk, et al.
Published: (2025-01-01) -
Association of Obstructive Sleep Apnea and Nocturnal Hypoxemia With the Circadian Rhythm of Myocardial Infarction
by: Xiaochen Liu, et al.
Published: (2025-02-01) -
The effect of continuous positive airway pressure therapy on atrial fibrillation in patients with obstructive sleep apnea
by: Jiancheng Hu, et al.
Published: (2025-01-01) -
One step closer to solving the mystery of the anti‐inflammatory effects of glucagon‐like peptide‐1 receptor agonists
by: Hirotaka Watada
Published: (2025-02-01) -
Association Between Weight Loss and Changes in Optimal Positive Airway Pressure Levels in Patients With Obstructive Sleep Apnea
by: Ji Ho Choi, et al.
Published: (2024-12-01)